Ilomedin (Iloprost Trometamol)

Iloprost Trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as a sterile solution for intravenous infusion intended for intravenous use. It is employed to manage pulmonary arterial hypertension and to treat digital ulcers associated with systemic sclerosis, providing vasodilatory and antiplatelet effects in these conditions.

GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance and reliable delivery.

Ilomedin acts on the prostacyclin pathway to provide vasodilation in pulmonary vascular disease.

Pulmonary arterial hypertension: improves exercise capacity and reduces pulmonary vascular resistance. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and lowers the incidence of new ulcers.

Ilomedin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Flushing: transient warmth and reddening of the skin. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Jaw pain: discomfort during chewing. - Hypotension: mild blood‑pressure drop. - Cough: dry or productive.

Serious or Rare Side Effects: - Severe hypotension: marked blood‑pressure reduction requiring intervention. - Pulmonary edema: fluid accumulation in the lungs. - Bleeding: increased risk due to antiplatelet action. - Thrombocytopenia: low platelet count. - Arrhythmia: irregular heart rhythm. - Anaphylaxis: rare severe allergic reaction.

When using Ilomedin, several precautionary measures should be observed to ensure patient safety.

Monitor blood pressure: check regularly during infusion. Adjust infusion rate in hypotension: reduce speed if systolic pressure falls. Caution in bleeding disorders: evaluate risk before administration. Avoid use after recent myocardial infarction: assess cardiac status. Pregnancy safety unknown: weigh benefits against potential risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Concomitant potent vasodilators (e.g., nitrates): may cause severe hypotension. - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other prostacyclin analogs: additive vasodilatory effects.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish antiplatelet benefit. - Calcium channel blockers: potential enhancement of blood‑pressure lowering. - ACE inhibitors: possible additive hypotensive effect.